News
Zacks Investment Research on MSN11h
Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales DownRegeneron Pharmaceuticals, Inc. REGN reported first-quarter 2025 adjusted earnings per share (EPS) of $8.22, which missed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback